AU Patent

AU2010253950C1 — Respiratory delivery of active agents

Assigned to Pearl Therapeutics Inc · Expires 2015-09-17 · 11y expired

What this patent protects

Compositions, methods and systems are provided for pulmonary or nasal delivery of two or more active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending particles, in which the active agent par…

USPTO Abstract

Compositions, methods and systems are provided for pulmonary or nasal delivery of two or more active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending particles, in which the active agent particles and suspending particles form a co-suspension within the suspension medium.

Drugs covered by this patent

Patent Metadata

Patent number: AU2010253950C1
Jurisdiction: AU
Classification: —
Expires: 2015-09-17
Drug substance claim: No
Drug product claim: No
Assignee: Pearl Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.